VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 109 filers reported holding VIKING THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,843,363 | +0.7% | 618,190 | +47.5% | 0.02% | +5.9% |
Q2 2023 | $6,794,811 | -41.3% | 419,174 | -39.7% | 0.02% | -48.5% |
Q1 2023 | $11,583,488 | -2.6% | 695,705 | -45.0% | 0.03% | -10.8% |
Q4 2022 | $11,892,767 | +343.3% | 1,265,188 | +28.3% | 0.04% | +311.1% |
Q3 2022 | $2,683,000 | -10.9% | 986,323 | -5.3% | 0.01% | -10.0% |
Q2 2022 | $3,011,000 | -19.3% | 1,042,002 | -16.2% | 0.01% | -9.1% |
Q1 2022 | $3,732,000 | -13.1% | 1,244,092 | +33.3% | 0.01% | +22.2% |
Q4 2021 | $4,294,000 | -22.0% | 933,481 | +6.5% | 0.01% | -25.0% |
Q3 2021 | $5,503,000 | +11.0% | 876,324 | +5.8% | 0.01% | +9.1% |
Q2 2021 | $4,959,000 | -30.2% | 827,944 | -26.3% | 0.01% | -38.9% |
Q1 2021 | $7,102,000 | +334.6% | 1,122,831 | +286.9% | 0.02% | +260.0% |
Q4 2020 | $1,634,000 | +334.6% | 290,220 | +349.1% | 0.01% | +400.0% |
Q3 2020 | $376,000 | -88.7% | 64,624 | -86.0% | 0.00% | -93.8% |
Q2 2020 | $3,330,000 | +11.7% | 461,900 | +18.6% | 0.02% | +33.3% |
Q4 2018 | $2,981,000 | – | 389,620 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 250,000 | $2,005,000 | 5.90% |
Sio Capital Management, LLC | 731,453 | $5,866,000 | 1.40% |
KNOTT DAVID M | 218,102 | $1,749,000 | 0.71% |
ArrowMark Colorado Holdings LLC | 8,813,578 | $70,685,000 | 0.63% |
DAFNA Capital Management LLC | 209,200 | $1,678,000 | 0.58% |
Park West Asset Management LLC | 1,545,075 | $12,391,000 | 0.52% |
SPHERA FUNDS MANAGEMENT LTD. | 590,000 | $4,732,000 | 0.39% |
Cornerstone Capital, Inc. | 245,796 | $1,971,000 | 0.28% |
Ikarian Capital, LLC | 150,000 | $1,203,000 | 0.20% |
Ikarian Capital, LLC | 150,000 | $1,203,000 | 0.20% |